No sooner had Perkin-Elmer Corp. stepped up the human genome mapping race by joining efforts with The Institute for Genomic Research 's Craig Venter to form Celera Genomics Inc.[See Deal]. Incyte Genetics' mission: complete a map of the human genome within a year; create a large-scale genome sequence database; and generate single nucleotide polymorphism (SNP) data for every human gene. This poses a direct challenge to PE which, just months earlier, boasted that Celera would get the mapping job done in three years and thus beat the Human Genome Project's expected completion date of 2005.
Mark Bodmer, Hexagen's CEO and the newly named President of Incyte Genetics, argues that Incyte is ahead in the race...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?